NCT03961698 2023-08-14
MARIO-3
Infinity Pharmaceuticals, Inc.
Phase 2 Unknown
Clinical Trials
13 trialsNCT04917900 2022-10-10
Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer
West China Hospital
Phase 2 Unknown
NCT05322720 2022-04-12
HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Taizhou EOC Pharma Co., Ltd.
Phase 2 Unknown
NCT05291910 2022-03-23
Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer
ChineseAMS
Phase 4 Unknown
NCT04780347 2021-03-03
Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer
Fudan University
Phase 2 Unknown
NCT04681911 2020-12-23
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT04639271 2020-11-20
Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT03994107 2020-01-22
Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer
Peking Union Medical College
Phase 1/2 Unknown
NCT03647514 2018-12-10
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT03647280 2018-12-07
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT01830244 2017-07-02
Neonab
Barwon Health
Phase 2 Unknown
NCT01625429 2012-11-09
Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer
Shanghai Cancer Hospital, China
Phase 2 Unknown
NCT01647672 2012-07-25
Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer
Tianjin Medical University
Phase 2/3 Unknown